SBRT improved local progression-free survival over RFA in small recurrent HCC, particularly in tumors 2 cm or less.

People with cirrhosis are at an increased risk of liver cancer. Treatment may include surgery, a liver transplant, ablation therapy (a needle or probe is used to kill cancer cells), embolization ...

St. David’s Medical Center in Austin is the first hospital in Central Texas to offer histotripsy, a noninvasive ultrasound ...

The different types of cells in the liver can form several types of malignant (cancerous) and benign (non-cancerous) tumors. These tumors have different causes, are treated differently, and have ...

For unresectable or metastatic liver cancer, the TPST-1120-301 trial of amezalpat combination therapy has received a “Study May Proceed” letter from the FDA. From “Boy Meets World” actress Danielle ...

The American Cancer Society’s estimates for primary liver cancer and intrahepatic bile duct cancer in the United States for 2025 are: About 42,240 new cases (28,220 in men and 14,020 in women) will be ...

Development of a methylation-based, tissue-agnostic test for the detection of molecular residual disease by circulating tumor DNA. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal ...

liver tumor ablation has received the greatest attention and has been the subject of a large number of published reports. In this article, the authors review the technical developments and early ...

Radiofrequency ablation (RFA) and microwave ablation (MWA) are both treatments to the liver. RFA uses radio waves and MWA uses microwaves ... Your doctor or nurse monitors you closely during and after ...

aDepartment of Surgery, Campus Charité Mitte–Campus Virchow-Klinikum, Charité–Universitätsmedizin Berlin, 10117 Berlin, Germany bDepartment of Hematology, Oncology, and Cancer Immunology, ...

Which Approach Should Be Used? The development of laparoscopic surgery has changed the approach to treatment of benign liver tumors. Currently, laparoscopic liver resection is feasible and safe ...